American Society of Hematology (ASH) President Kenneth Anderson said that the annual meeting, set for next month in Atlanta, will include plenty more data with chimeric antigen receptor (CAR) T cells, highlighting the approach's much-celebrated ability to build for patients an "autologous immune army."